Ken Fisher Regeneron Pharmaceuticals, Inc. Transaction History

Fisher Asset Management, LLC

$229 Billion
Q2 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 5,665 shares of REGN stock, worth $4.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,665

Previous 5,814 2.56%

Holding current value

$4.7 Million

Previous $5.6 Million 6.42%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $131,596 - $159,607	-149 Reduced 2.56%	5,665 $5.95 Million
Q1 2024 May 09, 2024	BUY	$902.69 - $993.35 $173,316 - $190,723	192 Added 3.42%	5,814 $5.6 Million
Q4 2023 Mar 05, 2024	SELL	$775.18 - $881.7 $10,077 - $11,462	-13 Reduced 0.23%	5,622 $4.94 Million
Q4 2023 Feb 06, 2024	BUY	$775.18 - $881.7 $375,962 - $427,624	485 Added 9.42%	5,635 $4.95 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $150,954 - $184,072	-218 Reduced 4.06%	5,150 $4.24 Million
Q2 2023 Dec 12, 2023	BUY	$700.03 - $830.35 $152,606 - $181,016	218 Added 4.23%	5,368 $3.86 Million
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $484,420 - $574,602	692 Added 14.8%	5,368 $3.86 Million
Q1 2023 Dec 12, 2023	SELL	$680.49 - $826.97 $532,823 - $647,517	-783 Reduced 15.2%	4,367 $3.59 Million
Q1 2023 May 01, 2023	BUY	$680.49 - $826.97 $47,634 - $57,887	70 Added 1.52%	4,676 $3.84 Million
Q4 2022 Feb 03, 2023	SELL	$705.89 - $766.39 $9,176 - $9,963	-13 Reduced 0.28%	4,606 $3.32 Million
Q3 2022 Nov 08, 2022	BUY	$573.97 - $724.32 $28,698 - $36,216	50 Added 1.09%	4,619 $3.18 Million
Q2 2022 Aug 09, 2022	BUY	$548.35 - $738.84 $1,645 - $2,216	3 Added 0.07%	4,569 $2.7 Million
Q1 2022 May 05, 2022	SELL	$595.12 - $698.43 $386,828 - $453,979	-650 Reduced 12.46%	4,566 $3.19 Million
Q4 2021 Feb 02, 2022	BUY	$543.48 - $670.97 $77,174 - $95,277	142 Added 2.8%	5,216 $3.29 Million
Q3 2021 Oct 26, 2021	SELL	$574.03 - $680.96 $48,792 - $57,881	-85 Reduced 1.65%	5,074 $3.07 Million
Q2 2021 Jul 27, 2021	BUY	$472.8 - $558.54 $20,803 - $24,575	44 Added 0.86%	5,159 $2.88 Million
Q1 2021 Apr 27, 2021	SELL	$446.73 - $548.2 $50,033 - $61,398	-112 Reduced 2.14%	5,115 $2.42 Million
Q4 2020 Jan 29, 2021	SELL	$478.3 - $607.98 $21,045 - $26,751	-44 Reduced 0.83%	5,227 $2.53 Million
Q3 2020 Nov 10, 2020	BUY	$544.75 - $658.21 $70,817 - $85,567	130 Added 2.53%	5,271 $2.95 Million
Q2 2020 Aug 07, 2020	SELL	$493.32 - $643.92 $986 - $1,287	-2 Reduced 0.04%	5,141 $3.21 Million
Q1 2020 Apr 28, 2020	SELL	$336.18 - $494.43 $48,746 - $71,692	-145 Reduced 2.74%	5,143 $2.51 Million
Q4 2019 Feb 12, 2020	SELL	$274.13 - $376.51 $43,586 - $59,865	-159 Reduced 2.92%	5,288 $1.99 Million
Q3 2019 Oct 29, 2019	BUY	$273.46 - $318.39 $4,922 - $5,731	18 Added 0.33%	5,447 $1.51 Million
Q2 2019 Jul 30, 2019	SELL	$299.6 - $414.82 $29,660 - $41,067	-99 Reduced 1.79%	5,429 $1.7 Million
Q1 2019 Apr 22, 2019	BUY	$372.08 - $439.57 $1.59 Million - $1.87 Million	4,264 Added 337.34%	5,528 $2.27 Million
Q4 2018 Jan 25, 2019	SELL	$335.82 - $403.04 $4,701 - $5,642	-14 Reduced 1.1%	1,264 $472,000
Q3 2018 Oct 24, 2018	SELL	$351.14 - $408.51 $106,044 - $123,370	-302 Reduced 19.11%	1,278 $516,000
Q2 2018 Jul 09, 2018	BUY	$284.6 - $344.99 $71,150 - $86,247	250 Added 18.8%	1,580 $545,000
Q1 2018 May 11, 2018	SELL	$315.82 - $393.78 $83,692 - $104,351	-265 Reduced 16.61%	1,330 $458,000
Q1 2018 Apr 19, 2018	BUY	$315.82 - $393.78 $41,056 - $51,191	130 Added 8.87%	1,595 $549,000
Q4 2017 Jan 24, 2018	SELL	$358.63 - $469.95 $39,090 - $51,224	-109 Reduced 6.93%	1,465 $551,000
Q3 2017 Oct 17, 2017	BUY	$431.38 - $504.0 $678,992 - $793,296	1,574	1,574 $704,000

Others Institutions Holding REGN

# of Institutions

1,483

Shares Held

85.7M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account